GSK

Gsk Plc-spon Adr

7 super-investor ownerscombined $2.55Blargest position 3.5%

7 of the 83 super-investors we track hold GSK, worth a combined $2.55B per their latest 13F filings. The largest position: Hillman Capital Management at 3.5% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 29 of 100 (how strongly the cohort backs it) — ranked #399 of 742 stocks. Conviction rising: 1 more super-investor hold it than in 2026Q1.

Share𝕏 in

Why super-investors own GSK

GSK is held by 7 super-investors in our cohort, with a combined position value of $2.6B. The highest-conviction owner is Hillman Capital Management at 3.5% of their portfolio. Cohort ownership has grown from 6 to 7 over the last four quarters — net interest is rising.

AI-synthesized from 13F filings. Not investment advice.

Cohort owners over time

2022Q2 → 2026Q2

How many of the cohort members held this stock each quarter.

Now: 7

Peak: 7

Owners (7) · click any column to sort

#↑	Manager	% Port.	History	Value	Shares
1	Dodge & Cox Funds	1.3%	16q	$2.53B	48,197,514
2	Kahn Brothers Group	1.6%	5q	$9M	160,982
3	Joel Greenblatt	<0.1%	14q	$8M	151,573
4	Hillman Capital Management	3.5%	16q	$5M	92,383
5	Tweedy Browne	0.3%	15q	$4M	81,527
6	Richard Pzena	<0.1%	5q	$1M	24,507
7	Sarah Ketterer	<0.1%	17q	$375K	7,163